UA100955C2 - Oxazine derivatives and use thereof in the treatment of neural disorders - Google Patents

Oxazine derivatives and use thereof in the treatment of neural disorders

Info

Publication number
UA100955C2
UA100955C2 UAA201202035A UAA201202035A UA100955C2 UA 100955 C2 UA100955 C2 UA 100955C2 UA A201202035 A UAA201202035 A UA A201202035A UA A201202035 A UAA201202035 A UA A201202035A UA 100955 C2 UA100955 C2 UA 100955C2
Authority
UA
Ukraine
Prior art keywords
treatment
oxazine derivatives
neural disorders
oxazine
derivatives
Prior art date
Application number
UAA201202035A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Сангамеш Бадігер
Муралі Чебролу
Матіас Фредеріксен
Філіпп Хольцер
Констанца Гурт
Лей Лі
Гуй Ліу
Райнер Мартін Люенд
Райнер Махауер
Генрік Мьобітц
Ульф Ньюманн
Ріта Рамос
Генріх Рюегер
Міхель Шефер
Маріна Тінтельнот-Бломлей
Сім Якоб Венстра
Маркус Вегтлье
Ксін Ксіонг
Original Assignee
Новартіс Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартіс Аг filed Critical Новартіс Аг
Priority claimed from PCT/CN2011/077119 external-priority patent/WO2012006953A1/en
Publication of UA100955C2 publication Critical patent/UA100955C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed are oxazine derivatives of formula (I) having BACH inhibitory activity, wherein all of the variables are as defined in the specification, in free form or in salt form, their preparation methods, their medical use and medicaments comprising them. EMBED ISISServer (I)
UAA201202035A 2010-07-13 2011-07-13 Oxazine derivatives and use thereof in the treatment of neural disorders UA100955C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36370210P 2010-07-13 2010-07-13
PCT/CN2011/077119 WO2012006953A1 (en) 2010-07-13 2011-07-13 Oxazine derivatives and their use in the treatment of neurological disorders

Publications (1)

Publication Number Publication Date
UA100955C2 true UA100955C2 (en) 2013-02-11

Family

ID=47561948

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201202035A UA100955C2 (en) 2010-07-13 2011-07-13 Oxazine derivatives and use thereof in the treatment of neural disorders

Country Status (2)

Country Link
AR (1) AR081996A1 (en)
UA (1) UA100955C2 (en)

Also Published As

Publication number Publication date
AR081996A1 (en) 2012-11-07

Similar Documents

Publication Publication Date Title
TN2012000067A1 (en) Oxazine derivatives and their use in the treatment of neurological disorders
AU2015205914B2 (en) 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections
MX343706B (en) Novel heterocyclic derivatives.
PH12015501965B1 (en) Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
MX340533B (en) 1,6- diazabicyclo [3,2,1] octan- 7 - one derivatives and their use in the treatment of bacterial infections.
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
TN2014000175A1 (en) Novel purine derivatives and their use in the treatment of disease
TN2012000249A1 (en) Pyrazine derivatives and their use in the treatment of neurological disorders
MX2013006591A (en) Controlled release oral dosage forms of poorly soluble drugs and uses thereof.
EA201590870A1 (en) AMINO-SUBSTITUTED IMIDAZO [1,2-a] Pyridinecarboxamides and their use
MY169980A (en) Bisaryl-linked aryltriazolones and their use
MX344238B (en) Tetrazole compounds and methods of making and using same.
MX356755B (en) Fumigillol type compounds and methods of making and using same.
CY1114757T1 (en) OXAZINE PRODUCTS AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
MY150931A (en) Substituted oxazolidinones and their use
ZA201805358B (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
WO2016004413A3 (en) Gls1 inhibitors for treating disease
WO2017011356A3 (en) Mcj inhibitors for use in treating drug-induced diseases and conditions
UA118474C2 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2015005733A (en) Tricyclic compounds for use in the treatment and/or control of obesity.
WO2014029888A3 (en) Branched or macrocyclic polyamines and uses thereof
UA109359C2 (en) TREATMENT OF SKIN DISEASES AND STATES
WO2013038200A3 (en) Neurodevelopmental disorders
PH12015500282A1 (en) N-acylhydrazone derivatives for selective t cell inhibitor and anti-lymphoid malignancy drug
UA100955C2 (en) Oxazine derivatives and use thereof in the treatment of neural disorders